
Sign up to save your podcasts
Or


Episode #2 of a 2-part series. Part 2 is all about how to handle specific scenarios and clinical pearls. We delve into methotrexate optimization, what to do when therapy fails, the safety of JAK inhibitors, pregnancy management in RA, DMARDs and malignancy, palindromic rheumatism, perioperative management, biosimilars and more.
By Dr. Karim Ladak5
181181 ratings
Episode #2 of a 2-part series. Part 2 is all about how to handle specific scenarios and clinical pearls. We delve into methotrexate optimization, what to do when therapy fails, the safety of JAK inhibitors, pregnancy management in RA, DMARDs and malignancy, palindromic rheumatism, perioperative management, biosimilars and more.

1,866 Listeners

497 Listeners

49 Listeners

126 Listeners

3,343 Listeners

115 Listeners

9,132 Listeners

120 Listeners

195 Listeners

513 Listeners

364 Listeners

71 Listeners

180 Listeners

236 Listeners

20 Listeners